PortfoliosLab logoPortfoliosLab logo
HIMS vs. EMA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HIMS vs. EMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hims & Hers Health, Inc. (HIMS) and Emera Inc (EMA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HIMS achieves a -13.49% return, which is significantly lower than EMA's 13.96% return.


HIMS

1D
-14.20%
1M
-14.10%
6M
-5.17%
YTD
-13.49%
1Y
-50.99%
3Y*
50.14%
5Y*
26.71%
10Y*
ALL TIME*
16.62%

EMA

1D
0.26%
1M
3.88%
6M
12.59%
YTD
13.96%
1Y
22.97%
3Y*
5Y*
10Y*
ALL TIME*
22.72%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$22.03M$20.24M$20.41M
$469.29M$508.05M$558.75M

HIMS vs. EMA - Yearly Performance Comparison


2026 (YTD)2025
HIMS
Hims & Hers Health, Inc.
-13.49%-39.15%
EMA
Emera Inc
13.96%11.17%

Correlation

The correlation between HIMS and EMA is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.11

Correlation (All Time)
Calculated using the full available price history since May 28, 2025

-0.13

Fundamentals

Market Cap

HIMS:

$6.27B

EMA:

$16.81B

EPS

HIMS:

-$0.05

EMA:

CA$3.55

PS Ratio

HIMS:

2.87

EMA:

2.72

PB Ratio

HIMS:

14.38

EMA:

2.57

Total Revenue (TTM)

HIMS:

$2.37B

EMA:

CA$8.59B

Gross Profit (TTM)

HIMS:

$1.70B

EMA:

CA$2.83B

EBITDA (TTM)

HIMS:

$16.04M

EMA:

CA$2.56B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HIMS vs. EMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMS
HIMS Risk / Return Rank: 2323
Overall Rank
HIMS Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
HIMS Sortino Ratio Rank: 2323
Sortino Ratio Rank
HIMS Omega Ratio Rank: 2424
Omega Ratio Rank
HIMS Calmar Ratio Rank: 2222
Calmar Ratio Rank
HIMS Martin Ratio Rank: 2525
Martin Ratio Rank

EMA
EMA Risk / Return Rank: 8888
Overall Rank
EMA Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
EMA Sortino Ratio Rank: 8585
Sortino Ratio Rank
EMA Omega Ratio Rank: 8282
Omega Ratio Rank
EMA Calmar Ratio Rank: 9292
Calmar Ratio Rank
EMA Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIMS vs. EMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Emera Inc (EMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HIMSEMADifference
Sharpe ratioReturn per unit of total volatility

-2.20

Sortino ratioReturn per unit of downside risk

-2.87

Omega ratioGain probability vs. loss probability

0.94

1.28

-0.34

Calmar ratioReturn relative to maximum drawdown

-0.66

3.89

-4.54

Martin ratioReturn relative to average drawdown

-1.02

10.13

-11.15

HIMS vs. EMA - Sharpe Ratio Comparison

The current HIMS Sharpe Ratio is -0.57, which is lower than the EMA Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of HIMS and EMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HIMS vs. EMA - Drawdown Comparison

The maximum HIMS drawdown since its inception was -87.29%, which is greater than EMA's maximum drawdown of -5.93%. Use the drawdown chart below to compare losses from any high point for HIMS and EMA.


Loading charts...

Drawdown Indicators


HIMSEMADifference

Max Drawdown

Largest peak-to-trough decline

-87.29%

-5.93%

-81.36%

Max Drawdown (1Y)

Largest decline over 1 year

-78.06%

-5.93%

-72.13%

Max Drawdown (3Y)

Largest decline over 3 years

-78.88%

Max Drawdown (5Y)

Largest decline over 5 years

-78.88%

Current Drawdown

Current decline from peak

-59.14%

-0.29%

-58.85%

Average Drawdown

Average peak-to-trough decline

-43.35%

-1.72%

-41.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

50.21%

2.27%

+47.94%

Volatility

HIMS vs. EMA - Volatility Comparison

Hims & Hers Health, Inc. (HIMS) has a higher volatility of 23.91% compared to Emera Inc (EMA) at 5.39%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than EMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HIMSEMADifference

Volatility (1M)

Calculated over the trailing 1-month period

23.91%

5.39%

+18.52%

Volatility (6M)

Calculated over the trailing 6-month period

71.82%

10.95%

+60.87%

Volatility (1Y)

Calculated over the trailing 1-year period

90.35%

14.15%

+76.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.71%

14.16%

+69.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.38%

14.16%

+63.22%

Dividends

HIMS vs. EMA - Dividend Comparison

HIMS has not paid dividends to shareholders, while EMA's dividend yield for the trailing twelve months is around 3.87%.


PositionTTM2025
EMA
Emera Inc
3.87%2.12%
HIMS
Hims & Hers Health, Inc.
0.00%0.00%

Financials

HIMS vs. EMA - Financials Comparison

This section allows you to compare key financial metrics between Hims & Hers Health, Inc. and Emera Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B2.50BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
608.10M
2.48B
(HIMS) Total Revenue
(EMA) Total Revenue
Please note, different currencies. HIMS values in USD, EMA values in CAD

HIMS vs. EMA - Profitability Comparison

The chart below illustrates the profitability comparison between Hims & Hers Health, Inc. and Emera Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
65.3%
30.5%
Portfolio components
HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Hims & Hers Health, Inc. reported a gross profit of 396.79M and revenue of 608.10M. Therefore, the gross margin over that period was 65.3%.

EMA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Emera Inc reported a gross profit of 756.95M and revenue of 2.48B. Therefore, the gross margin over that period was 30.5%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Hims & Hers Health, Inc. reported an operating income of -78.32M and revenue of 608.10M, resulting in an operating margin of -12.9%.

EMA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Emera Inc reported an operating income of 626.62M and revenue of 2.48B, resulting in an operating margin of 25.3%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Hims & Hers Health, Inc. reported a net income of -92.12M and revenue of 608.10M, resulting in a net margin of -15.2%.

EMA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Emera Inc reported a net income of 583.50M and revenue of 2.48B, resulting in a net margin of 23.5%.


Frequently Asked Questions


HIMS and EMA have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HIMS has higher volatility (23.91%) compared to EMA (5.39%). In terms of maximum drawdown, HIMS dropped -87.29% vs EMA's -5.93%.

EMA currently has the higher Sharpe Ratio (1.63 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HIMS and EMA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer